To hear about similar clinical trials, please enter your email below
Trial Title:
Health Benefits of Writing Therapy Among Asian American Cancer Survivors
NCT ID:
NCT06367959
Condition:
Cancer
Study type:
Interventional
Study phase:
N/A
Overall status:
Recruiting
Study design:
Allocation:
Randomized
Intervention model:
Single Group Assignment
Primary purpose:
Supportive Care
Masking:
None (Open Label)
Intervention:
Intervention type:
Behavioral
Intervention name:
Esays
Description:
Participants will write about their experiences One (1) time each week for 3 weeks at the
beginning of the study and then 1 more time 9 months later. Participants will be asked to
write about their experiences with cancer in English or Chinese and to write as much as
they can for about 20-30 minutes for each essay.
Arm group label:
Control condition
Arm group label:
Intervention Condition
Intervention type:
Behavioral
Intervention name:
Questionnaires
Description:
Participants will answer a questionnaire at the beginning of the study and then 3, 6, and
12 months later.
Participants will also answer a questionnaire about their thoughts on writing and on the
study after they complete the third essay.
Arm group label:
Control condition
Arm group label:
Intervention Condition
Summary:
To learn more about participant experience as a Asian American immigrant breast cancer
survivor and how writing about participant experiences may affect participant's health.
Detailed description:
Primary Objective:
To determine the effects of writing therapy on QOL and perceived stress at the 6- and
12-month follow-ups.
Secondary Objective:
To discover the effects of writing therapy on stress biomarkers and perceived stress at
the 3-month follow-up.
To explore the psychosocial and cultural mechanisms responsible for the benefits of
writing therapy by using mixed methods.
Criteria for eligibility:
Criteria:
Inclusion Criteria:
- Adult (aged 18 and older) diagnosed with stage 0-III cancer (or acute leukemia in
remission/ chronic myeloid leukemia in chronic phase).
- Self-identified as Asian, Asian Americans, any Asian or Asian American subgroup
(Chinese, Vietnamese, Indian, Korean, etc.) ethnic/cultural background
- Completed primary treatment, including surgery, chemotherapy, and/or radiation
therapy, immunotherapy, or targeted therapy within the preceding 5 years.
- Comfortable reading in English or in Chinese.
Exclusion Criteria:
- Inability to provide informed consent.
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
MD Anderson Cancer Center
Address:
City:
Houston
Zip:
77030
Country:
United States
Status:
Recruiting
Contact:
Last name:
Qian Lu, MD, PHD
Phone:
713-745-8324
Email:
qlu@mdanderson.org
Investigator:
Last name:
Qian Lu, MD, PHD
Email:
Principal Investigator
Start date:
July 27, 2023
Completion date:
August 31, 2026
Lead sponsor:
Agency:
M.D. Anderson Cancer Center
Agency class:
Other
Source:
M.D. Anderson Cancer Center
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06367959
http://www.mdanderson.org
